BIO - Bio-Rad Laboratories Inc. - Ordinary Shares - Class A
Close
337.32
3.610 1.070%
Share volume: 205,414
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$333.71
3.61
1.08%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-28 | 2023-02-17 | 2023-05-05 | 2023-08-04 | 2023-10-27 | 2024-02-16 | 2024-05-08 | 2024-08-02 | |
| Assets | |||||||||
| Total Assets | 12.058 B | 13.502 B | 13.667 B | 11.978 B | 11.896 B | 12.299 B | 12.610 B | 9.688 B | |
| Current Assets | 3.140 B | 3.158 B | 3.277 B | 3.139 B | 3.147 B | 3.048 B | 3.061 B | 3.056 B | |
| Inventories | 685.850 M | 719.316 M | 752.937 M | 776.600 M | 775.818 M | 780.517 M | 783.369 M | 803.693 M | |
| Other Current Assets | 166.320 M | 147.783 M | 169.029 M | 142.445 M | 148.997 M | 166.094 M | 181.524 M | 185.389 M | |
| Short Term Investments | 166.320 M | 147.783 M | 169.029 M | 142.445 M | 148.997 M | 166.094 M | 181.524 M | 185.389 M | |
| Total Receivables | 432.302 M | 494.645 M | 498.273 M | 491.575 M | 457.402 M | 489.017 M | 444.809 M | 445.506 M | |
| Current Cash | 1.850 B | 1.791 B | 1.851 B | 1.723 B | 1.759 B | 1.607 B | 1.646 B | 1.616 B | |
| Total Non-current Assets | 8.918 B | 10.344 B | 10.390 B | 8.839 B | 8.749 B | 9.251 B | 9.549 B | 6.632 B | |
| Property Plant Equipment | 461.112 M | 498.612 M | 506.454 M | 514.013 M | 511.389 M | 529.007 M | 522.364 M | 533.767 M | |
| Other Assets | 101.774 M | 94.599 M | 95.513 M | 100.064 M | 98.470 M | 94.850 M | 92.873 M | 98.189 M | |
| Intangible Assets | 325.076 M | 332.147 M | 327.828 M | 328.710 M | 314.187 M | 320.514 M | 313.602 M | 307.093 M | |
| Goodwill | 399.589 M | 406.488 M | 407.757 M | 411.519 M | 406.953 M | 413.569 M | 412.817 M | 412.116 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 12.058 B | 13.502 B | 13.667 B | 11.978 B | 11.896 B | 12.299 B | 12.610 B | 9.688 B | |
| Total liabilities | 3.605 B | 3.886 B | 3.904 B | 3.531 B | 3.480 B | 3.558 B | 3.559 B | 2.910 B | |
| Total current liabilities | 570.677 M | 568.708 M | 589.623 M | 581.982 M | 558.176 M | 522.799 M | 466.154 M | 486.961 M | |
| Accounts Payable | 142.746 M | 135.041 M | 160.979 M | 149.535 M | 111.859 M | 144.625 M | 102.750 M | 126.693 M | |
| Other liabilities | 205.091 M | 195.912 M | 199.249 M | 202.294 M | 186.121 M | 195.113 M | 192.418 M | 193.537 M | |
| Current long term debt | 448.000 K | 465.000 K | 519.000 K | 476.000 K | 476.000 K | 486.000 K | 487.000 K | 483.000 K | |
| Long term debt | 1.197 B | 1.198 B | 1.198 B | 1.198 B | 1.199 B | 1.199 B | 1.199 B | 1.200 B | |
| Other liabilities | 205.091 M | 195.912 M | 199.249 M | 202.294 M | 186.121 M | 195.113 M | 192.418 M | 193.537 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 8.454 B | 9.615 B | 9.764 B | 8.447 B | 8.416 B | 8.741 B | 9.051 B | 6.779 B | |
| Common stock | 29.733 M | 29.680 M | 29.596 M | 29.355 M | 29.102 M | 28.783 M | 28.518 M | 28.395 M | |
| Retained earnings | 9.047 B | 9.898 B | 9.967 B | 8.805 B | 8.911 B | 9.261 B | 9.645 B | 7.479 B |